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Metastases of colorectal cancers into injured livers, such as
chronic viral hepatitis (Utsunimoiya et al, 1999), liver cirrhosis
(Seymour and Charnley, 1999) and fatty liver (Hayashi et al,
1997), are rare, with an incidence ranging from 0–8%. Recent
studies suggest that in these hepatic disorders, changes in liver-
associated immunity may play an important role in hindering
hepatic metastasis formation. However the mechanism remains
illusive (Okuno et al, 1998). 
For metastatic tumour cells to become established and develop
into overt lesions, they must first evade immune surveillance at the
secondary sites. Cytotoxic T lymphocytes (CTLs) and natural
killer (NK) cells constitute the first line of cellular defence against
invading cancer cells in the liver. Activated CTLs and NK cells
may conduct cytotoxicity on target cells by Fas receptor (FasR)
and Fas ligand (FasL) interaction (Nagata, 1997). Although
lymphocytes infiltrating the metastatic colorectal cancers in livers
express high levels of FasL, the metastatic cancer cells can evade
FasR-mediated cell killing induced by CTLs. It has been demon-
strated that highly metastatic colorectal cancer cells lack FasR
expression, and thus are resistant to FasL-induced apoptosis. This
was suggested to be a pre-requisite for the colonization of the
malignant cells in the liver (Yoong et al, 1999). 
However, expression of Fas receptors on colorectal cancer cells can
be up-regulated by pro-inflammatory cytokines produced by
macrophages upon activation, which thus enhance the sensitivity of
tumour cells to CTL-mediated cytotoxicity (Möller et al, 1994;
Krammer et al, 1998). This phenomenon underlines the possible
concerting role of macrophages and CTLs in controlling hepatic
metastasis of colorectal cancers. In a rat model of experimentally
induced hepatic metastases, a prominent increase in the number of
Kupffer cells, macrophages residing in liver, was observed,
suggesting that these cells were involved in the immune response
against tumour cell deposits in the liver (Thomas et al, 1993).
Nevertheless, despite an increase in Kupffer cells, together with FasL-
positive CTLs, these cells failed to contain the development of metas-
tases. This is because the Kupffer cells residing in normal livers were
not activated, as evaluated by various activation criteria. Hence, it was
suggested that Kupffer cells in normal livers were not effective in the
defence against metastasis of colorectal cancers (Griffini et al, 1996). 
In cirrhotic livers, however, Kupffer cells are activated and
release constitutive amount of proinflammatory factors (Gressner,
1996). The activated Kupffer cells assorting with FasL expressing
CTLs may be able to eliminate metastatic tumour cells in cirrhotic
livers. But the interaction between colon cancer cells and pre-
activated Kupffer cells from cirrhotic livers has not yet been studied.
Therefore, the aim of the present study was to explore the influ-
ence of activated Kupffer cells from cirrhotic rat livers on hepatic
colonization of colon cancer cells, and to investigate the regulatory
effect of these macrophages on FasR expression as well as FasR-
mediated apoptosis in colon cancer cells. 
MATERIALS AND METHODS 
Animals and liver cirrhosis model 
Male Fischer rats (220–250 g; Charles River, Sulzfeld, Germany)
were used throughout the experiments. All animals were kept
under routine laboratory conditions and received care in compli-
ance with the institution’s guidelines. Liver cirrhosis was induced
by CCl4 in the presence of phenobarbital as previously described
(Armendáriz-Borunda et al, 1989). Cirrhosis of the liver was
confirmed by histological examination. Untreated animals were
used as healthy controls. 
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Preparation of Kupffer cells 
Kupffer cells were isolated from CCl4-induced liver cirrhosis and
from healthy control rats as described elsewhere (Armendáriz-
Borunda et al, 1989). Briefly, after perfused with Gey’s balanced
saline solution (GBSS) solution supplemented with 0.2%
pronase E and 0.8 mg ml–1 DNase (Sigma Chemical Co, St Louis,
MO, USA) via the portal vein, the liver was removed and cut into
small pieces, which were then incubated at 37˚C for 45 min with
the same solution. Hepatocytes were then removed by centrifu-
gation. The supernatant was saved and the isolation of Kupffer
cells was achieved by centrifugation at 600 ´ g, 4˚C, for 15 min
in a 17.5% solution of metrizamide (Accurate Chemicals and
Scientific Co, Westbury, NY) in GBSS. The interface layer
containing Kupffer cells was isolated and washed in PBS.
Further purification was achieved by allowing the cells to adhere
to plastic culture plates at 37˚C for 2 h. Nonadherent cells were
removed by washing, and the adhered Kupffer cells were
cultured in Dulbecco’s modified Eagle medium (DMEM)
containing 10% fetal calf serum (FCS) at 37˚C for 24 h for
further studies. The purity of Kupffer cells after 24 h culture as
assayed by a-naphthyl acetate esterase (Sigma) staining was
greater than 95%. The viability of cells was always greater than
95% as determined by trypan blue exclusion. Kupffer cell-
conditioned media (KCM) was prepared by removing medium
supernatant from Kupffer cells after 24 h of culture, which was
then filtered through Millipore (0.22 mm) for further study. 
Colon cancer cell line and treatment 
The colon adenocarcinoma cell line RCN-9, a dimethylhydrazine-
induced colon carcinoma of Fischer rats (Inoue et al, 1991), was
obtained from ATCC (Rockville, MD). RCN-9 cells were main-
tained in DMEM with 10% FCS and 0.2 mmol l–1l L-glutamine
(Sigma Chemical Co, St Louis, MO, USA). For treatment with
Kupffer cell-conditioned media (KCM), RCN-9 cells were
cultured in 75-cm2 flasks, and incubated for 48 h in freshly
prepared KCM under standard incubator conditions. 
Induction of hepatic metastases 
Tumour cell suspensions were prepared by enzymatic detach-
ment of the RCN-9 cells with trypsin-EDTA solution (Sigma
Chemical Co, St Louis, MO, USA) at room temperature. After
centrifugation, cell concentrations were re-suspended in DMEM
to the required concentration. Induction of hepatic metastases
was performed by infusing RCN-9 cell suspensions to rat livers
(Okuno et al, 1998). Briefly, a laparotomy was performed under
ether anaesthesia and a loop of the small intestine was exposed.
A suspension of 1 ´ 106 RCN-9 cells in 0.5 ml DMEM was
slowly injected into a mesenteric vein under microscopic vision
with a 0.4 ´ 12 mm needle, followed by ligation of the vein. The
animals were sacrificed after 14 days, and macroscopic metas-
tases, which appeared as pale nodules larger than 5 mm under the
liver capsule and often confluent, were searched and counted.
Untreated RCN-9 cells were infused to cirrhotic livers of rats
induced by CCl4 (n = 20), and to normal livers of healthy control
rats (n = 20). Additionally, RCN-9 cells treated with KCM from
cirrhotic rat livers were infused to normal livers of healthy rats
(n = 20). 
Isolation of tumour-infiltrating lymphocytes 
Tumour-infiltrating lymphocytes in metastatic lesions of non-
cirrhotic livers were isolated as described previously (Yoong and
Adams, 1998). Liver tissues with metastatic tumours were cut into
small pieces, and were added to medium without FCS but with
collagenase II (0.05%), DNase (0.002%) and hyaluronidase (2.5 U
ml–1; Sigma Chemical Co, St Louis, MO, USA), which were then
incubated at 37˚C 1 h on a shaker. The tissue digest was then
passed through a nylon mesh to obtain a single cell suspension that
was washed with PBS until the supernatant became clear. The
single cell suspension was layered onto Ficoll Hypaque
(Lymphoprep, Biovalley Co, Rockville, MD) and centrifuged at
1200 g for 30 min at room temperature. Lymphocytes and tumour
cells were recovered from the interface. 
For further isolation of infiltrating lymphocytes, the cells were
incubated with biotin-labelled anti-CD5 (Serotec Camon Labor-
Service GmbH, Wiesbaden, Germany) for 45 min at 4˚C, washed
twice in MACS buffer (0.5% BSA, EDTA and Mg2+ and Ca2+ free
PBS) and incubated with streptavidin-MACS beads (Miltenyi
Biotec, Auburn, CA) for 15 min at 4˚C. They were washed twice
in MACS buffer and run on a MACS column. The method resulted
in an enrichment of T lymphocytes by up to 90% or more. 
In-vitro cytotoxic assay 
The in-vitro cytotoxic effect of Kupffer cells or tumour-infiltrating
lymphocytes (TILs) on RCN-9 cells was individually assessed
by radioactive release assays. Tumour target cells, RCN-9, in
their exponential growth phase were labelled by incubation for
24 h in medium containing 0.2 mCi ml–1 [3H]-thymidine (>2500
Ci mmol–1 Amersham-Buchler, Braunschweig, Germany). After
labelling, RCN-9 cells were washed 3 times with HBSS to
remove unbound radioisotope, harvested by a brief trypsinization,
and re-suspended in DMEM with 10% FCS. 
Then target tumour cells were seeded into 96-well flat-bottom-
microtiter plates (Nunc, Wiesbaden, Germany) at a density of 
1 ´ 104 well–1 and incubated with medium alone for 24 h at 37˚C
under 5% CO2. In some experiments, target cells were pre-incu-
bated in the presence of the antagonistic anti-FasR-blocking anti-
body clone ZB4 (Biovalley Co, Rockville, MD) at a final
concentration of 2 mg ml–1 for 1 hour. Freshly isolated TILs or
Kupffer cells were added as effector cells at various effector-to-
target ratios, and the final volume per well was 200 ml DMEM
with 10% FCS. Radiolabelled target cells were also plated alone as
a negative control. Effector and target cells (with various E:T
ratios) were co-cultured for 72 h for Kupffer cell-mediated cyto-
toxicity assay and for 24 h for TIL-mediated one. After being
washed twice with PBS, the adherent viable cells were lysed with
0.1 ml of 0.1 N KOH, and the macromolecular DNA was trans-
ferred and bound onto a glass fibre filter mat (Wallac, Freiburg,
Germany). Fragmented DNA was washed through the filter by 4
washes of 0.25 ml water. The radioactivity of intact chromosomal
DNA retained on each filter was measured by a liquid scintillation
counter (LKB/Wallac, Freiburg, Germany). Cytotoxicity was
calculated using the following formula: 
Cytotoxicity (%) = ((S 2 E) / S) ´ 100 
Where E (experimental) was the cpm of retained DNA in the
presence of effector cells, and S (spontaneous) is the one in the
absence of effector cells. Assessment of FasL-induced apoptosis 
Sensitivity of RCN-9 cells to FasL-induced apoptosis was further
determined by incubation with the recombinant human soluble (rhs)
Fas ligand (Alexis, Läufelfingen, Switzerland) (Müschen et al,
1998) at concentrations of 10, 100, 500 and 1000 ng ml–1, or in
DMEM with 10% FCS as control. After 24 h of rhsFasL incubation,
the number of apoptotic cells was determined by the terminal
deoxynucleotide transferase-mediated dUTP nick end labelling
(TUNEL) assay (Boehringer Mannheim GmbH, Mannheim,
Germany) and flow cytometry. Briefly, tumour cells were per-
meabilized with 0.1% Triton X-100 for 5 minutes, and incubated for
60 min at 37˚C in a labelling TUNEL-reaction mixture containing
terminal deoxynucleotidyl transferase (TdT) reaction buffer (10.0
ml), bromodeoxyuridine (Br-dUTP; 8.0 ml), H2O (32.25 ml), and
TdT (0.75 ml). The reaction was then terminated with addition of a
rinse buffer. Incorporated Br-dUTP was detected after the addition
of fluorescein-labelled anti-bromodeoxyuridine antibody (5.0 ml)
and incubation for 30 min at room temperature in the dark. Flow
cytometric analysis was performed, and data were expressed as
percentage of TUNEL-positive tumour cells. 
Immunofluorescence analysis 
Quantification of Fas receptors expressed on colon cancer cells
was performed by immunofluoresence flow cytometric analysis.
After washing twice, RCN-9 cells were incubated with anti-rat
FasR mAb (M20, Santa Cruz Biotechnology, Santa Cruz, CA) for
30 min at 4˚C and washed in PBS containing 2% FCS. FITC-
conjugated secondary antibody (Dako Corp, Carpinteria, CA) was
added to the cells for 30 min at 4˚C. Cells were washed again in
PBS containing 2% FCS, and the intensity of fluorescence was
analysed with FACScan flow cytometer and LYSIS II software
(Nippon Becton Dickinson, Tokyo, Japan). Isotype-matched
control antibody was used to determine nonspecific binding. PHA-
activated peripheral blood lymphocytes (PBL) isolated from
normal rats served as positive controls for FasR expression. A total
of 10 000 cells were examined for each determination. Data were
expressed as relative fluorescence intensity (RFI = mean fluores-
cence intensity of cells stained with anti-Fas mAb/mean fluores-
cence intensity of cells stained with control mAb). 
RT-PCR assays 
FasR mRNA expression in colon cancer cells and TNFa as well as
IL-1a mRNA expression in Kupffer cells from cirrhotic and
normal rat livers were monitored by semi-quantitative RT-PCR.
RNA extraction and reverse transcription were performed as previ-
ously described (Boekelheide et al, 1998). PCR was performed on
cDNA using the primers (sense and anti-sense) for the amplifica-
tion of FasR, TNFa, IL-1a and a housekeeping gene, b-actin. All
primers were designed according to the published sequences
(Nadeau et al, 1995; Boekelheide et al, 1998). 
Thermal cycling was as follows: denaturation at 94˚C for 1 min,
annealing at 65˚C for 1 min, and extension at 72˚C for 1 min. 40
cycles were performed for FasR, 35 cycles for TNFa and IL-1a, and
28 cycles for the b-actin PCR. Primers were used at a final concen-
tration of 0.1 mM each, dNTPs at 50 mm, MgCl2 at 1.5 mM, Taq
DNA polymerase at 1.0 m per 50 ml reaction. PCR products were
separated by electrophoresis in 2% agarose gels and stained with
ethidium bromide, and products of 682 bp were predicted for FasR,
295 bp for TNFa, 623 for IL-1a and 762 bp for b-actin, respectively.
The target bands were analysed densitometrically by using a GS-700
Imaging Densitometer (BioRad, Hercules, CA). Cytokine cDNA
was semiquantitated by densitometric comparison with b-actin from
the same sample. PHA-activated PBL isolated from normal rats
served as positive controls for FasR mRNA expression. 
Statistical analysis 
Data were given as mean ± SEM (n ³ 5). Statistical analysis was
performed by one-way analysis of variance (ANOVA) and
comparisons among groups were performed by Bonferroni’s
multiple-comparison  t-test. Significance level was set at P < 0.05. 
RESULTS 
Metastasis formation in cirrhotic and normal rat livers 
After 14 days of inoculation with untreated RCN-9 cells, liver
metastases were macroscopically visible in 18 out of 20 (90%) rats
without liver cirrhosis, while only 8 out of 20 (40%) rats with liver
cirrhosis developed hepatic metastases (Table 1, P < 0.05).
However, when RCN-9 cells pre-treated with KCM from cirrhotic
rat livers (cirrhotic KCM) were used to inoculate normal rat livers,
the number of rats developing hepatic metastases fell to 11 out of
20 (55%, P < 0.05), which was comparable to metastasis forma-
tion of untreated cells in cirrhotic livers (P > 0.05). Metastases
were never observed at the injection site or at any other organ
within the time of this study. 
Direct cytotoxicity of Kupffer cells on tumour cells 
Co-cultivation of RCN-9 cells with Kupffer cells isolated from
both cirrhotic and normal rat livers did not result in significant
difference in specific killing (% cytotoxicity) at any E:T ratio (P >
0.05, Figure 1). Additionally, despite the increase of E:T ratio, the
cytotoxicity of cirrhotic Kupffer cells on RCN-9 cells remained
stable at a low level (P > 0.05). 
Effect of cirrhotic KCM on TIL-mediated tumour
cytotoxicity 
As shown by [3H]-release assay (Figure 2A), treatment with normal
KCM did not increase the specific killing in RCN-9 cells mediated
Cirrhotic Kupffer cells sensitize colon cancer cells to apoptosis 1267
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Table 1 A comparison of metastasis formation of cirrhotic KCM treated and
untreated RCN-9 colon carcinoma cells in cirrhotic and normal rat livers 
Animal groups Metastasis (%) Non-metastasis (%) 
Untreated RCN-9 cells  18 (90%) 2 (10%) 
inoculated to normal livers 
(n = 20)
Untreated RCN-9 cells  8 (40%)* 12 (60%)* 
inoculated to cirrhotic livers 
(n = 20)
Cirrhotic KCM treated RCN-9  11 (55%)* 9 (45%)*
cells inoculated to normal livers 
(n = 20)
*P < 0.05 as compared with the animals with untreated RCN-9 cells
inoculated to normal livers. 1268 E Song et al 
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by co-culture of TILs as compared with untreated cells (P > 0.05),
and the cytotoxicity of TILs to both untreated and normal KCM-
treated cells remained stable at low levels as the E:T ratio increased
(P > 0.05). However, treatment with cirrhotic KCM sensitized the
tumour cells to TIL- mediated cytotoxicity, as the lytic effect in these
cells was significantly more intense than untreated cells at the same
E:T ratio (P < 0.01), reaching 46.9 ± 5.3% at E:T ratio of 10:1.
Furthermore, increases of E:T ratio resulted in elevation of TIL-
mediated cytotoxicity in a dose-dependent manner (P < 0.05). 
To determine whether TIL-mediated cell lysis was FasR-
mediated, we pre-incubated target tumour cells with 2 mgm l –1 of the
antagonistic anti-FasR blocking antibody clone ZB4, which remained
in the culture medium during exposure to isolated lymphocytes. ZB4
treatment specifically inhibited TIL-mediated cytotoxicity to cirrhotic
KCM-treated RCN-9 cells (P < 0.01) (Figure 2B). However such
treatment did not modify the cytolytic activity of lymphocytes toward
normal KCM-treated cells or untreated cells (data not shown).
Furthermore, as reported elsewhere the ZB4 monoclonal antibody
alone did not influence cytolysis of RCN-9 cells (not shown). 
Effect of cirrhotic KCM on FasL-induced apoptosis 
After incubation for 24 h in the presence of rhsFasL at concentra-
tions up to 1 mgm l –1, a dose-dependent increase of apoptotic cells
was observed in tumour cells treated with cirrhotic KCM (Figure
3). Percentage of cell death was elevated to 12.6 ± 1.6 at
10 ng ml–1 of rhsFasL, which was significantly higher than control
(P < 0.01), and reached 55.4 ± 7.1 at 1 mgm l –1 of rhsFasL. In
contrast, apoptotic percentage of RCN-9 cells treated with normal
KCM, as well as untreated cells, remained stable with the increase
of rhsFasL concentration. Even at a concentration (1 mgm l –1) 100
times higher than the one necessary to induce apoptosis in rat
hepatocytes (Boekelheide et al, 1998), percentage of apoptotic
cancer cells in this group did not differ from control (P > 0.05). 
Effect of cirrhotic KCM on Fas receptor expression of
tumour cells 
In order to evaluate whether the sensitizing effect of cirrhotic
KCM on colon cancer cells was mediated by up-regulating Fas
receptor levels on tumour cell surface, we detected Fas receptor
expression on RCN-9 cells at both protein and mRNA levels. As
shown by immunofluoresence flow cytometry analysis (Figure 4),
RCN-9 cells treated with normal KCM, as well as untreated cells,
failed to express significant amount of Fas receptors (RFI
3.13 ± 1.74 for normal KCM-treated cells; 4.27 ± 2.05 for
untreated cells), which was quantitatively much lower than that
seen in PHA-activated PBLs serving as a positive control (53.5 ±
16.4; P < 0.01). In contrast, RCN-9 cells showed a prominent
increase in FasR surface density after exposure to cirrhotic KCM,
with an RFI of 127.7 ±24.6 which was higher than that of the posi-
tive control (P < 0.05). This paralleled the changes of FasR mRNA
expression in RCN-9 cells upon treatment with cirrhotic KCM, as
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Figure 1 Kupffer cell-mediated cytotoxicity against RCN-9 cells. [3H]-
labelled RCN-9 cells (target cells) were co-cultivated for 72 h with Kupffer
cells (effector cells) isolated from normal or cirrhotic rat liver at different E:T
ratios. Results were expressed as the mean (± SEM) cytotoxicity (%) of
Kupffer cells (n ³ 5) 
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Figure 2 TIL-mediated cytotoxicity against RCN-9 cells. Results were
expressed as the mean (± SEM) cytotoxicity (%) of Kupffer cells (n ³ 5).
(A) Untreated, normal KCM-treated or cirrhotic KCM-treated RCN-9 cells
(target cells) labelled with [3H] were co-cultivated for 48 h with tumour-
infiltrating lymphocytes (effector cells) at different E:T ratios. *P < 0.01 as
compared with the cytotoxicity against untreated RCN-9 cells at the same 
E:T ratio; §P < 0.05 as compared with the cytotoxicity against cirrhotic 
KCM-treated RCN-9 cells at a lower E:T ratio. (B) Cirrhotic KCM-treated
RCN-9 cells (target cells) without or with ZB4 pre-incubation were 
co-cultivated for 48 h with tumour-infiltrating lymphocytes at different E:T
ratios. *P < 0.01 as compared with KCM-treated RCN-9 cells without ZB4 
pre-incubation at the same E:T ratio these cells expressed much higher levels of FasR mRNA (3.26 ±
1.49 times b-actin) in comparison to cells treated with normal
KCM (0.54 ± 0.27 times b-actin) and untreated cells (0.39 ± 0.15
times b-actin) (P < 0.01). 
Cytokine expression in cirrhotic Kupffer cells 
To further determine whether activated Kupffer cells isolated from
cirrhotic rat livers express proinflammatory factors, we deter-
mined the mRNA expression of TNFa and IL-1a in these cells. In
Kupffer cells isolated from normal rat livers, only basal expression
of TNFa (0.28 ± 0.06 times b- actin) and IL-1a (0.42 ± 0.14 times
b-actin) mRNA was observed. In sharp contrast, activated Kupffer
cells isolated from cirrhotic rat livers expressed much higher
mRNA levels of TNFa (2.76 ± 0.53 times b-actin; P < 0.01) and
IL-1a (3.07 ± 0.84 times b-actin;  P < 0.01) respectively as
compared to normal ones. 
DISCUSSION 
In the present study, we found that colon cancer cells preferentially
metastasized to normal rat livers, and less frequently to cirrhotic
ones induced by CCl4. Our results support previous clinical data,
and confirm that cirrhotic livers are not a favourable environment
for metastatic tumour cells (Seymour and Charnley, 1999). More
interestingly, treatment of colon cancer cells with Kupffer cell-
conditioned media from cirrhotic livers dramatically reduced the
occurrence of metastases in normal rat livers to the extent that was
comparable to metastases in cirrhotic livers. This phenomenon
suggests that Kupffer cells from cirrhotic livers contribute to the
inhibition of hepatic colonization of colon cancer cells. 
It has been shown that during the development of the inflamma-
tory process in cirrhotic livers, Kupffer cells proliferate exten-
sively and are activated to produce proinflammatory cytokines,
which play a central role in mediating cytotoxicity to parenchymal
cells and inducing the inflammatory response (Gressner, 1996).
Hence, it is reasonable to extrapolate that Kupffer cells from
cirrhotic livers directly kill colon cancer cells, and thus impede the
formation of liver metastases. However, Kupffer cells from
cirrhotic livers were not effective in killing colon cancer cells
directly in our co-culture system even at a high effector to target
ratio (40:1). Similarly, Hauptmann et al (1993) have also demon-
strated that activated macrophages are not effective in inhibiting
the proliferation of tumour cells in vitro. These findings suggest
that the hindering effect of Kupffer cells from cirrhotic livers on
hepatic colonization of colon cancer cells does not depend on
direct tumour cytotoxicity. 
Nevertheless, our study showed that treatment of colon cancer
cells with cirrhotic KCM, but not with normal KCM, resulted in an
increase of cytotoxicity mediated by tumour-infiltrating lympho-
cytes in a dose-dependent manner. This suggests that despite inef-
ficacy in direct tumour cell killing, Kupffer cells from cirrhotic
livers are able to sensitise colon cancer cells to TIL-mediated lysis. 
It has been well established that FasR and FasL interaction is a
major mechanism of T-cell-mediated cytotoxicity (Nagata, 1997).
Tumour-infiltrating lymphocytes (TILs) of colon cancers, as well
as metastatic ones, express Fas ligand on their cell surfaces
(O’Connell et al, 1998; Yoong et al, 1999). In order to confirm that
the present TIL-induced cytotoxicity towards cirrhotic KCM-
treated colon cancer cells was FasR-mediated, an antagonistic
anti-FasR–blocking antibody which alone does not modify cytol-
ysis (Houghton et al, 1997), was used before the cytotoxic assay.
Application of the antibody completely abolished TIL-mediated
cytotoxicity to target tumour cells, suggesting that this kind of cell
killing involves Fas–FasL interaction. In addition, the sensitivity
of cirrhotic KCM-treated colon cancer cells to FasR-mediated
apoptosis was further corroborated by increased apoptosis induced
by recombinant human soluble Fas ligand in a dose-dependent
manner. 
Cirrhotic Kupffer cells sensitize colon cancer cells to apoptosis 1269
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In contrast, we found that normal KCM-treated or untreated
RCN-9 cells are refractory to FasR-mediated apoptosis, which is
in agreement with findings in human colon cancer cells (Möller et
al, 1994; O’Connell et al, 1996; Krammer et al, 1998; O’Connell
et al, 1998). FasR-resistance of colon cancer cells is thought to be
involved in the mechanism of immune evasion, and associated
with their metastatic phenotype (Möller et al, 1994; O’Connell et
al, 1998; Yoong et al, 1999). Restoration of colon cancer cell
sensitivity to Fas-mediated apoptosis is able to facilitate them to
TIL-mediated killing, and has been proposed to be an effective
immunotherapy for containing the malignancy (Tamura et al,
1995; Houghton et al, 1997; Micheau et al, 1997; Bonnotte et al,
1998; Fukazawa et al, 1999). Thus, sensitization of colon cancer
cells to Fas-mediated apoptosis by cirrhotic Kupffer cells, as
demonstrated in the present study presumably contributes to the
immunologic impedance of cirrhotic livers against metastasis
formation of colorectal cancers. 
As a sufficient level of Fas receptors has been shown to be
required for the induction of apoptosis in colonic epithelial cells
(Tillman et al, 1998; von Reyher et al, 1998), we further studied
the mechanism for FasR-sensitivity alternation in differently
treated colon cancer cells by examining the levels of their FasR
expression. We found that the untreated RCN-9 cells, as well as
the ones treated with normal KCM, expressed Fas receptor mRNA
and protein at much lower levels than positive controls. Similarly,
Möller et al (1994), have demonstrated that expression of Fas
protein in the colon is progressively reduced during the transfor-
mation of normal epithelium to benign neoplasms, adenocarci-
nomas, and ultimately, to metastases, as only 10% of adenomas
exhibited reduced Fas expression compared with 88% of carci-
nomas, and complete absence of Fas was most common in
metastatic tumours. Hence, loss of Fas expression contributes to
the unresponsiveness of colon cancer cells to FasR-mediated
apoptosis. Nevertheless, our findings showed that treatment with
cirrhotic, instead of normal KCM tremendously up-regulated FasR
surface density and FasR mRNA expression in colon cancer cells
to the level similar to positive control, which paralleled its sensit-
izing effect on FasR-mediated apoptosis. Houghton et al (1997)
have suggested that signal transduction of FasR-mediated apop-
tosis in colon cancer cells is intact and functional, and restoration
of sufficiently high levels of Fas receptors allows transduction of
the signal from the cell surface to induce apoptosis. This position
is supported by the findings that a variety of chemotherapeutic
drugs (Micheau et al, 1997, 1999) and anti-tumour cytokines
(Möller et al, 1994), such as TNF-a and IFN-g, exhibit an indirect
cytotoxic effect on colon cancer cells by enhancing their expres-
sion of Fas receptors, and thus preparing the tumour cells to be
eliminated by immune system using a Fas-dependent pathway.
Thus, the up-regulation of Fas receptor expression on colon cancer
cells upon treatment with cirrhotic KCM revealed in the current
study probably contributes to sensitization of the tumour cells to
FasR-mediated apoptosis induced by Kupffer cells from cirrhotic
livers. 
It has been known that Kupffer cells in cirrhotic livers function
differently from the macrophages in other tissue or in non-
cirrhotic livers by releasing pro-inflammatory cytokines
(Gressner, 1996). Our present study confirmed that Kupffer cells
isolated from cirrhotic rat livers expressed elevated levels of
TNFa and IL-1a mRNA. As tumour necrosis factor and inter-
leukin-1 have been shown to enhance the level of FasR expression
on cell surfaces (Litton et al, 1996; Moulian et al, 1999), we
suggest that over-production of these cytokines by Kupffer cells in
cirrhotic livers probably accounts for their modulating effects on
colon cancer cells. However, further studies are needed to assess
the regulating effects of cytokines and growth factors produced by
Kupffer cells in cirrhotic liver on FasR-sensitivity of colon cancer
cells. 
In summary, our study presents the first experimental evidence
that alterations in liver-associated immunity during hepatic
cirrhosis provides an immunologic impediment to hepatic colo-
nization of colon cancers. We concluded that Kupffer cells in
cirrhotic livers sensitize metastatic colon cancer cells to FasR-
mediated apoptosis by up-regulating their expression of Fas recep-
tors, which thus prepare the malignancies to be eliminated by
tumour-infiltrating lymphocytes. Hence, activation of Kupffer
cells during hepatic cirrhosis on one hand results in tissue damage
and fibrogenesis in livers, but on the other hand inhibits the
hepatic matastasis formation of colon cancers. 
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